Literature DB >> 21661434

Null-margin mesohepatectomy for centrally located hepatocellular carcinoma in cirrhotic patients.

Xiong-Ying Miao1, Ji-Xiong Hu, Wei-Dong Dai, De-Wu Zhong, Shou-Zhi Xiong.   

Abstract

BACKGROUND/AIMS: Anatomic mesohepatectomy is often anatomically restricted by the hilar structure and, therefore, difficult to perform with an adequate resection margin. Especially, in the case of a tumor which is in contact without infiltration with the critical intrahepatic vessels, mesohepatectomy has to be performed without a surgical margin.
METHODOLOGY: From January 2005 to December 2009, thirty-seven patients with centrally located HCC underwent anatomic mesohepatectomy without resection margin in our hospital. The surgical techniques, clinicopathological characteristics and outcomes were reviewed.
RESULTS: Mean operative time was 210 minutes (range 130 to 310 minutes) and mean intraoperative blood loss was 950 mL (range 150 to 4,500 mL). Mean postoperative hospitalization was 12.6 days (range 10 to 32 days). Postoperative complications were encountered in 37.8% of patients. The 1-, 3-, and 5-year recurrence-free survival rate was 75.1%, 39.3%, 22.5%, respectively, and the 1-, 3- and 5-year overall survival rate was 91.9%, 60.4%, 28.5%, respectively.
CONCLUSION: Null-margin mesohepatectomy is an oncologically radical but parenchyma-sparing hepatic resection. In patients with impaired functional liver reserve and with centrally located tumors in contact without infiltration with major vessels, expected zero resection margins should not be considered as a contraindication for surgery, and null-margin mesohepatectomy should be recommended as a reasonable surgical option.

Entities:  

Mesh:

Year:  2011        PMID: 21661434

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

1.  Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma.

Authors:  Chun-Han Chen; Tzu-Hao Huang; Cheng-Chih Chang; Wei-Feng Li; Ting-Lung Lin; Chih-Chi Wang
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Outcomes of central bisectionectomy for hepatocellular carcinoma.

Authors:  Thomas K Gallagher; Albert C Y Chan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-11-21       Impact factor: 3.647

3.  Intensity-modulated radiotherapy following null-margin resection is associated with improved survival in the treatment of intrahepatic cholangiocarcinoma.

Authors:  Angela Y Jia; Jian-Xiong Wu; Yu-Ting Zhao; Ye-Xiong Li; Zhi Wang; Wei-Qi Rong; Li-Ming Wang; Jing Jin; Shu-Lian Wang; Yong-Wen Song; Yue-Ping Liu; Hua Ren; Hui Fang; Wen-Qing Wang; Xin-Fan Liu; Zi-Hao Yu; Wei-Hu Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

4.  R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma.

Authors:  Weibo Yu; Weiqi Rong; Liming Wang; Fan Wu; Quan Xu; Jianxiong Wu
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

5.  Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.

Authors:  Liming Wang; Weihu Wang; Weiqi Rong; Zhuo Li; Fan Wu; Yunhe Liu; Yiling Zheng; Kai Zhang; Tana Siqin; Mei Liu; Bo Chen; Jianxiong Wu
Journal:  BMC Cancer       Date:  2020-07-01       Impact factor: 4.430

6.  Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels.

Authors:  Xuan Zheng; Bo Chen; Jian-Xiong Wu; Angela Y Jia; Wei-Qi Rong; Li-Ming Wang; Fan Wu; Yu-Ting Zhao; Ye-Xiong Li; Wei-Hu Wang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

7.  Early versus late recurrence of centrally located hepatocellular carcinoma after mesohepatectomy: A cohort study based on the STROBE guidelines.

Authors:  Jun Zhao; Wei Li; Jie Mao
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma.

Authors:  Lihong Liu; Yongjie Shui; Qianqian Yu; Yinglu Guo; Lili Zhang; Xiaofeng Zhou; Risheng Yu; Jianying Lou; Shumei Wei; Qichun Wei
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

9.  Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.

Authors:  Liming Wang; Weihu Wang; Xuesong Yao; Weiqi Rong; Fan Wu; Bo Chen; Mei Liu; Shengtao Lin; Yunhe Liu; Jianxiong Wu
Journal:  Oncotarget       Date:  2017-08-23

10.  Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.

Authors:  Bo Chen; Jian-Xiong Wu; Shu-Hui Cheng; Li-Ming Wang; Wei-Qi Rong; Fan Wu; Shu-Lian Wang; Jing Jin; Yue-Ping Liu; Yong-Wen Song; Hua Ren; Hui Fang; Yuan Tang; Ning Li; Ye-Xiong Li; Wei-Hu Wang
Journal:  Hepatology       Date:  2021-09-16       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.